GSK Unveils Pivotal Data on Oral Antibiotic Ahead of FDA Filing
22 Oct 2025 //
PRESS RELEASE
Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A
06 Sep 2022 //
GLOBENEWSWIRE
22 Oct 2025 //
PRESS RELEASE
06 Sep 2022 //
GLOBENEWSWIRE
Market Place
Sourcing Support